We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
SSA
276
South Street Advisors
New York
$13.2M +$17.9K +80 +0.1%
SCM
277
Suffolk Capital Management
New York
$13.2M +$12.2M +54,688 New
SA
278
Steadfast Advisors
New York
$13.1M -$6.17M -27,582 -34%
ODCM
279
Old Dominion Capital Management
Virginia
$12.8M -$21K -94 -2%
AIM
280
Artemis Investment Management
United Kingdom
$12.7M +$11.8M +52,540 New
ABI
281
Adamant Biomedical Investments
Switzerland
$12.6M +$11.7M +52,110 New
RI
282
Redwood Investments
Massachusetts
$12.6M -$1.04M -4,646 -8%
QI
283
Qualcomm Inc
California
$12.6M -$10.8M -48,463 -48%
IGM
284
Incline Global Management
New York
$12.3M +$51.5K +230 +0.5%
RP
285
Realm Partners
New York
$12.2M +$8.92M +39,873 +380%
RAM
286
Riggs Asset Management
Pennsylvania
$12.1M -$3.8K -17 -0%
CCM
287
Catapult Capital Management
New York
$12.1M +$7.83M +35,000 +233%
ARC
288
Absolute Return Capital
Massachusetts
$11.7M -$5.96M -26,622 -35%
COPPSERS
289
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$11.7M +$10.6M +47,366 +4,310%
GT
290
Glenmede Trust
Pennsylvania
$11.6M +$6.61M +29,547 +160%
WC
291
Wexford Capital
Florida
$11.3M +$5.83M +26,039 +124%
MRCM
292
M&R Capital Management
New Jersey
$11.3M -$357K -1,593 -3%
PG
293
PEAK6 Group
Illinois
$11.3M +$4.25M +19,001 +69%
OTPPB
294
Ontario Teachers' Pension Plan Board
Ontario, Canada
$11.2M +$3.95M +17,655 +62%
SMDAM
295
Sumitomo Mitsui DS Asset Management
Japan
$11M +$6.24M +27,888 +159%
ProShare Advisors
296
ProShare Advisors
Maryland
$10.9M +$2.81M +12,557 +38%
DM
297
Delphi Management
Massachusetts
$10.9M -$824K -3,681 -8%
EAM
298
Edge Asset Management
Washington
$10.6M -$184K -822 -2%
URS
299
Utah Retirement Systems
Utah
$10.6M +$3.04M +13,586 +45%
NPGCU
300
Napier Park Global Capital (US)
New York
$10.6M +$3.88M +17,328 +65%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.